Island Pharmaceuticals (ASX:ILA) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals Days Sales Outstanding?

Island Pharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.09 Mil. Island Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil.

The historical rank and industry rank for Island Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

ASX:ILA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 564.09 Med: 564.09 Max: 564.09
Current: 564.09

During the past 3 years, Island Pharmaceuticals's highest Days Sales Outstanding was 564.09. The lowest was 564.09. And the median was 564.09.

ASX:ILA's Days Sales Outstanding is ranked worse than
93.71% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs ASX:ILA: 564.09

Island Pharmaceuticals's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Island Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Island Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals Days Sales Outstanding Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Days Sales Outstanding

564.09

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Island Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Island Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's Days Sales Outstanding falls into.

Island Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Island Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0	+	0.017)	/	1 )	/	0.011	*	365
=	0.017					/	0.011	*	365
=	564.09

Island Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.017	+	0.159)	/	2 )	/	0	*	365 / 2
=	0.088					/	0	*	365 / 2
=	N/A

Island Pharmaceuticals (ASX:ILA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Island Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals (ASX:ILA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.

Island Pharmaceuticals (ASX:ILA) Headlines

No Headlines